It was imperative that Integrator Inc., a Fortune 200 solutions provider, had access to latest industry technologies and products for its solutions. The decision was to form many partnership to get access and acquire such technologies.
Vaxa was asked to develop a process to identify such companies. The result was to focus on the world's leading venture capital (VC) companies who invested in the industry that was of most interest.
Approach
Analyzed over 5000 VCs from US, Europe, andAsia-Pacific.
Developed an attribute-based model to determine the level of fit of each VC firms' allocation of investments with Integrator Inc. long term objectives.
Interviewed twenty (20) corporations who leveraged VC investments to develop a set of best practices for leveraging such strategies and tactics.
Outcome
Identified the top twenty-five (25) whose historical and future fund investment were aligned with the client's goals.
Prioritization of VC firm for immediate and longer term equity investments based on the investment attribute-based model.
A database of over 5000 venture capital companies that is continuously updated.
Client Results
Invested in over twelve (12) VC funds in North America and Europe.
Developd the capacity to get access and rights of first refusal to new and emerging technologies from emerging companies.